Belmont Medical Technologies Appoints Brian Larkin as CEO
Belmont Medical Technologies, renowned for its advanced fluid resuscitation and patient temperature management systems, has made a significant leadership change. Brian Larkin has stepped into the role of Chief Executive Officer, succeeding Brian Ellacott, effective immediately. A respected figure within the medical technology industry, Ellacott will continue to contribute as Executive Chair on the Board.
Brian Larkin's Extensive Experience
Larkin brings with him over thirty years of experience in medical technology and patient care. His career has been marked by a commitment to excellence in managing complex enterprises, crafting strategies that not only facilitate organic growth but also execute strategic acquisitions to broaden market reach and enhance financial outcomes.
Before joining Belmont, Larkin was the President and CEO of Comar, a medical packaging and device manufacturing company. Under his leadership, Comar underwent a reorganization that resulted in significant efficiencies and growth during its sale to Precision Concepts International. His previous position as President and CEO at SP Industries further demonstrates his capability, where he oversaw impressive revenue growth prior to its acquisition by ATS Corporation. He has also held leadership roles at LifeCell and Integra LifeSciences.
Belmont's Mission and Innovative Products
In his first statement as CEO, Larkin expressed his enthusiasm for Belmont's mission: "Belmont is dedicated to saving lives with The Belmont Rapid Infuser RI-2 and its innovative temperature management products. I am thrilled to be part of a company with exceptional products and the trust of its customers. I am excited to collaborate with the Belmont team in sustaining our momentum and charting the path for future growth."
Brian Ellacott praised Larkin's proven track record, stating, "We are fortunate to have Brian Larkin at the helm of Belmont. His extensive background in medical devices and patient-care solutions aligns perfectly with our innovative culture and our commitment to delivering superior medical products that merge technical ingenuity with exceptional quality standards."
Support from Audax Private Equity
Tim Porter, Managing Director at Audax Private Equity, expressed confidence in Larkin's leadership as well, highlighting his strong history in the medical technology realm. "We are eager to support Brian Larkin and the entire Belmont team as they continue to introduce cutting-edge critical care products aimed at improving patient outcomes and ultimately saving lives," Porter noted. Larkin’s expertise is viewed as essential in steering Belmont through this next growth phase.
Acknowledging Brian Ellacott's Impact
Young Lee, Partner and Co-President of Audax Private Equity, extended gratitude to Brian Ellacott for his exceptional leadership during his tenure. "Brian's impact on Belmont has been profound, and under his direction, the company experienced nearly fourfold growth since our investment in 2017. He has been an invaluable ally to Audax—both at Belmont and previously at Laborie Medical Technologies. We wish him every success in his well-deserved retirement," Lee remarked.
About Belmont Medical Technologies
Belmont Medical Technologies is committed to enhancing patient care with its innovative fluid resuscitation and temperature management solutions, utilized worldwide across medical facilities, military settings, and emergency medical services. Their signature product, The Belmont Rapid Infuser RI-2, utilizes advanced electromagnetic induction heating technology to manage fluid temperature and flow rate, a critical tool for patients facing severe blood loss. This technology has been recognized for saving thousands of lives globally, with features designed to prevent complications such as air embolism.
Another significant offering from Belmont is the portable, battery-operated buddy lite, developed for pre-hospital blood and fluid warming. The organization also provides advanced temperature management solutions, including the Allon system, which features the ThermoWrap patient garment, and the CritiCool system, accompanied by the CureWrap patient garment. These non-invasive technologies empower healthcare professionals to manage and maintain patient body temperature effectively.
About Audax Private Equity
Audax Private Equity, with its headquarters in Boston and additional offices in San Francisco, New York, London, and Hong Kong, operates as a prominent private equity platform focused on North American middle-market investments. Their approach aims to enhance value creation through a strategic Buy & Build strategy combined with the Audax Value Agenda, which seeks to maximize value at every stage of investment. As of early 2026, Audax managed around $19.5 billion in assets and has successfully invested in over 180 platforms along with more than 1,400 acquisitions since its inception.
Contact Information
For inquiries, contact Alexandra Rousseau, Senior Director of Global Marketing, at Belmont Medical Technologies.
Frequently Asked Questions
Who is the new CEO of Belmont Medical Technologies?
The new CEO is Brian Larkin, appointed to lead the company forward.
What is the focus of Belmont Medical Technologies?
Belmont specializes in fluid resuscitation and patient temperature management solutions.
What notable achievements does Brian Larkin have?
Larkin has over three decades of experience and has previously led successful organizations in the medical technology sector.
What products does Belmont offer?
Belmont’s premier product is The Belmont Rapid Infuser RI-2, along with various temperature management solutions.
What is Audax Private Equity's role with Belmont?
Audax Private Equity has been a key investor in Belmont, supporting its growth and innovation initiatives.
